Get the Stockscreener App
2.375
1.68%
-0.025
Xbiotech Inc stock is traded at $2.375, with a volume of 60,308.
It is down -1.68% in the last 24 hours and down -12.48% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$2.35
Open:
$2.31
24h Volume:
60,308
Relative Volume:
1.10
Market Cap:
$71.65M
Revenue:
$4.01M
Net Income/Loss:
$-38.53M
P/E Ratio:
-1.8849
EPS:
-1.26
Net Cash Flow:
$-32.27M
1W Performance:
-10.10%
1M Performance:
-12.48%
6M Performance:
-20.87%
1Y Performance:
-68.56%
1-Day Range:
$2.30
$2.35
1-Week Range:
$2.30
$2.56
52-Week Range:
$2.30
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.35 | 71.65M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
Is XBiotech Inc. stock near bottom after declineWeekly Trade Recap & Verified Momentum Watchlists - newser.com
Will XBiotech Inc. (4XB) stock outperform foreign stocksPortfolio Update Report & Verified Chart Pattern Signals - newser.com
Will XBiotech Inc. stock continue upward momentum2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Will XBiotech Inc. stock split attract more investorsPortfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Will XBiotech Inc. stock go up soon2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com
Will XBiotech Inc. stock benefit from automationWeekly Investment Report & Safe Capital Growth Tips - newser.com
Can XBiotech Inc. (4XB) stock sustain free cash flowJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
What risks investors should watch in XBiotech Inc. stockEarnings Trend Report & Daily Technical Stock Forecast Reports - newser.com
Is it too late to sell XBiotech Inc.Treasury Yields & AI Powered Market Entry Ideas - newser.com
How strong is XBiotech Inc. stock balance sheet2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Intraday pattern recognizer results for XBiotech Inc.July 2025 Outlook & Stock Portfolio Risk Management - newser.com
XBiotech (NASDAQ:XBIT) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
How XBiotech Inc. (4XB) stock trades after rate cutsWeekly Trend Report & Free Growth Oriented Trading Recommendations - newser.com
Can volume confirm reversal in XBiotech Inc.Quarterly Market Summary & Stepwise Swing Trade Plans - newser.com
XBiotech Inc. stock trend forecastMarket Performance Summary & AI Forecasted Entry and Exit Points - newser.com
Earnings visualization tools for XBiotech Inc.2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Will XBiotech Inc. (4XB) stock announce special dividendJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Should I hold or sell XBiotech Inc. stock in 2025Weekly Market Outlook & Short-Term High Return Strategies - fcp.pa.gov.br
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):